The contact email for BMN-111 phase 2 clinical trial has changed. Now is: firstname.lastname@example.org
This email is the central point for trial inquiries at this time. This is the contact for the Trial Specialist. BioMarin team works with Clinical Operations to answer trial related inquiries. Study identifier: NCT01603095
In this upgraded phase 2, patients aged 2 to 13.5 years, can be enrolled.